Hutch News

Hutch News

Stories tagged 'Transplant and Immunotherapy'

Improving cancer vaccines with T-cell programming nanoparticles

Dr. Matthias Stephan receives grant to develop cancer vaccine–optimizing, TCR-programming nanotechnology

July 31, 2018 | By Sabrina Richards / Fred Hutch News Service

Fred Hutch immunobioengineer Dr. Matthias Stephan has received an award to support the development of a combined T-cell programming, cancer-vaccine strategy to treat cancer.

View story >


3 new projects map out immune responses to cancers

Scientists aim to gather knowledge that improves future immunotherapies

July 30, 2018 | By Susan Keown / Fred Hutch News Service

The immune system has the potential to eradicate cancer. But cancers are expert escape artists, with numerous tools for shutting down or hiding from immune attack. Three research teams at Fred Hutch have launched new projects aimed at revealing some of these secrets and laying the groundwork for developing better immune-harnessing cancer therapies, or immunotherapies.

View story >


The legacy of a pioneering transplant immunologist

‘So much to be learned’: Dr. John Hansen reflects on the lives he’s saved and the answers still to come

July 11, 2018 | by Susan Keown / Fred Hutch News Service

Among his many contributions to bone marrow transplantation, Hansen helped define the rules for matching donors and patients and was a founding father of volunteer donor registries.

View story >


New guide helps clinicians navigate immunotherapy revolution in Merkel cell carcinoma

‘Real-world’ review accompanies new clinical care guidelines in rare skin cancer

June 28, 2018 | By Susan Keown / Fred Hutch News Service

Fred Hutchinson Cancer Research Center researchers have published a new guide to help clinicians navigate a recent revolution in care for advanced Merkel cell carcinoma, a rare and deadly skin cancer.

View story >


Poor quality of life in 1 in 5 caregivers of bone marrow transplant survivors

Largest-ever study IDs risk factors, paves way for interventions to help

June 28, 2018 | By Susan Keown / Fred Hutch News Service

Being the caregiver of a loved one with a serious illness can be a tough job — and one that's too often under the radar. In a new study, Fred Hutch researchers take a hard look at how some of these "silent supporters" are doing.

View story >


His immune system eradicated his melanoma. Could other patients’ bodies be taught to do the same thing?

How one man’s T cells are guiding the development of next-gen immunotherapies

June 19, 2018 | by Susan Keown / Fred Hutch News Service

Chris Pope's immune system eradicated his stage 4 melanoma on an immunotherapy clinical trial. Is it possible to genetically reprogram other patients' to do the same thing?

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.